SCHEMBL9347052

SCHEMBL9347052

N[C]([CH]c1c[nH]c2ccccc12)C(=O)O

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP2A6 P11509 1/20 0.54
▸ IMPDH2 P12268 1/20 0.54
▸ ALDH1A1 P00352 6/20 0.54
▸ HPGD P15428 5/20 0.54
▸ MAPT P10636 5/20 0.54
▸ MEN1 O00255 5/20 0.54
▸ KMT2A Q03164 5/20 0.54
▸ SMN1; SMN2 Q16637 4/20 0.54
▸ NPC1 O15118 3/20 0.54
▸ RAB9A P51151 3/20 0.54
▸ NFKB1 P19838 1/20 0.54
▸ NFKB2 Q00653 1/20 0.54
▸ RELA Q04206 1/20 0.54
▸ ATM Q13315 1/20 0.51
▸ HTT P42858 1/20 0.50
▸ GAA P10253 2/20 0.48
▸ CYP1A2 P05177 2/20 0.48
▸ CYP3A4 P08684 2/20 0.48
▸ KDM4E B2RXH2 3/20 0.46
▸ APP P05067 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2825118 0.86 CYP2A6 (0.61) CYP2A6IMPDH2ALDH1A1HPGDMAPT
SCHEMBL7773883 0.81 CYP2A6 (0.54) CYP2A6IMPDH2ALDH1A1HPGDMAPT
SCHEMBL787960 0.78 CYP2A6 (0.59) CYP2A6IMPDH2ALDH1A1HPGDMAPT
SCHEMBL5276244 0.75 MAPT (0.68) CYP2A6IMPDH2ALDH1A1HPGDMAPT
SCHEMBL5276252 0.75 MAPT (0.68) CYP2A6IMPDH2ALDH1A1HPGDMAPT
SCHEMBL30209646 0.75 MAPT (0.68) CYP2A6IMPDH2ALDH1A1HPGDMAPT
SCHEMBL531504 0.75 MEN1 (0.77) CYP2A6IMPDH2ALDH1A1HPGDMAPT
SCHEMBL15486685 0.75 MEN1 (0.77) CYP2A6IMPDH2ALDH1A1HPGDMAPT
SCHEMBL179873 0.75 MEN1 (0.77) CYP2A6IMPDH2ALDH1A1HPGDMAPT
SCHEMBL31357475 0.75 MEN1 (0.77) CYP2A6IMPDH2ALDH1A1HPGDMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5356794-A Purified enzymatic preparation derived from chromobacterium violaceum, method for preparing it and its use in the production of α, β-dehydrotryptophanyl-peptides COMMISSARIAT A L'ENERGIE ATOMIQUE (FR) 1994-10-18 — — US disclosed
Send feedback